Global T-Cell Immunotherapy Market Insights, Forecast to 2025

Publisher Name :
Date: 17-Apr-2019
No. of pages: 111
Inquire Before Buying

The global T-Cell Immunotherapy market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the T-Cell Immunotherapy market based on company, product type, end user and key regions.

This report studies the global market size of T-Cell Immunotherapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of T-Cell Immunotherapy in these regions.

This research report categorizes the global T-Cell Immunotherapy market by top players/brands, region, type and end user. This report also studies the global T-Cell Immunotherapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Adaptimmune

- Altor Bioscience Corporation

- Cellectis

- Juno Therapeutics

- Kite Pharma

- Novartis

- Takara Bio

- Unum Therapeutics

Market size by Product

- CAR-T

- TCR

- TIL Therapies

Market size by End User

- Stomach Cancer

- Lung Cancer

- Colorectal Cancer

- Esophagus Cancer

- Pancreatic Cancer

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global T-Cell Immunotherapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of T-Cell Immunotherapy market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global T-Cell Immunotherapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of T-Cell Immunotherapy submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of T-Cell Immunotherapy are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of T-Cell Immunotherapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global T-Cell Immunotherapy Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 T-Cell Immunotherapy Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global T-Cell Immunotherapy Market Size Growth Rate by Product
1.4.2 CAR-T
1.4.3 TCR
1.4.4 TIL Therapies
1.5 Market by End User
1.5.1 Global T-Cell Immunotherapy Market Size Growth Rate by End User
1.5.2 Stomach Cancer
1.5.3 Lung Cancer
1.5.4 Colorectal Cancer
1.5.5 Esophagus Cancer
1.5.6 Pancreatic Cancer
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global T-Cell Immunotherapy Market Size
2.1.1 Global T-Cell Immunotherapy Revenue 2014-2025
2.1.2 Global T-Cell Immunotherapy Sales 2014-2025
2.2 T-Cell Immunotherapy Growth Rate by Regions
2.2.1 Global T-Cell Immunotherapy Sales by Regions
2.2.2 Global T-Cell Immunotherapy Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 T-Cell Immunotherapy Sales by Manufacturers
3.1.1 T-Cell Immunotherapy Sales by Manufacturers
3.1.2 T-Cell Immunotherapy Sales Market Share by Manufacturers
3.1.3 Global T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2 T-Cell Immunotherapy Revenue by Manufacturers
3.2.1 T-Cell Immunotherapy Revenue by Manufacturers (2014-2019)
3.2.2 T-Cell Immunotherapy Revenue Share by Manufacturers (2014-2019)
3.3 T-Cell Immunotherapy Price by Manufacturers
3.4 T-Cell Immunotherapy Manufacturing Base Distribution, Product Types
3.4.1 T-Cell Immunotherapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers T-Cell Immunotherapy Product Type
3.4.3 Date of International Manufacturers Enter into T-Cell Immunotherapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global T-Cell Immunotherapy Sales by Product
4.2 Global T-Cell Immunotherapy Revenue by Product
4.3 T-Cell Immunotherapy Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global T-Cell Immunotherapy Breakdown Data by End User
6 North America
6.1 North America T-Cell Immunotherapy by Countries
6.1.1 North America T-Cell Immunotherapy Sales by Countries
6.1.2 North America T-Cell Immunotherapy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America T-Cell Immunotherapy by Product
6.3 North America T-Cell Immunotherapy by End User
7 Europe
7.1 Europe T-Cell Immunotherapy by Countries
7.1.1 Europe T-Cell Immunotherapy Sales by Countries
7.1.2 Europe T-Cell Immunotherapy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe T-Cell Immunotherapy by Product
7.3 Europe T-Cell Immunotherapy by End User
8 Asia Pacific
8.1 Asia Pacific T-Cell Immunotherapy by Countries
8.1.1 Asia Pacific T-Cell Immunotherapy Sales by Countries
8.1.2 Asia Pacific T-Cell Immunotherapy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific T-Cell Immunotherapy by Product
8.3 Asia Pacific T-Cell Immunotherapy by End User
9 Central & South America
9.1 Central & South America T-Cell Immunotherapy by Countries
9.1.1 Central & South America T-Cell Immunotherapy Sales by Countries
9.1.2 Central & South America T-Cell Immunotherapy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America T-Cell Immunotherapy by Product
9.3 Central & South America T-Cell Immunotherapy by End User
10 Middle East and Africa
10.1 Middle East and Africa T-Cell Immunotherapy by Countries
10.1.1 Middle East and Africa T-Cell Immunotherapy Sales by Countries
10.1.2 Middle East and Africa T-Cell Immunotherapy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa T-Cell Immunotherapy by Product
10.3 Middle East and Africa T-Cell Immunotherapy by End User
11 Company Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Details
11.1.2 Company Business Overview
11.1.3 Adaptimmune T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Adaptimmune T-Cell Immunotherapy Products Offered
11.1.5 Adaptimmune Recent Development
11.2 Altor Bioscience Corporation
11.2.1 Altor Bioscience Corporation Company Details
11.2.2 Company Business Overview
11.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Altor Bioscience Corporation T-Cell Immunotherapy Products Offered
11.2.5 Altor Bioscience Corporation Recent Development
11.3 Cellectis
11.3.1 Cellectis Company Details
11.3.2 Company Business Overview
11.3.3 Cellectis T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Cellectis T-Cell Immunotherapy Products Offered
11.3.5 Cellectis Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Details
11.4.2 Company Business Overview
11.4.3 Juno Therapeutics T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Juno Therapeutics T-Cell Immunotherapy Products Offered
11.4.5 Juno Therapeutics Recent Development
11.5 Kite Pharma
11.5.1 Kite Pharma Company Details
11.5.2 Company Business Overview
11.5.3 Kite Pharma T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Kite Pharma T-Cell Immunotherapy Products Offered
11.5.5 Kite Pharma Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Business Overview
11.6.3 Novartis T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Novartis T-Cell Immunotherapy Products Offered
11.6.5 Novartis Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Company Business Overview
11.7.3 Takara Bio T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Takara Bio T-Cell Immunotherapy Products Offered
11.7.5 Takara Bio Recent Development
11.8 Unum Therapeutics
11.8.1 Unum Therapeutics Company Details
11.8.2 Company Business Overview
11.8.3 Unum Therapeutics T-Cell Immunotherapy Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Unum Therapeutics T-Cell Immunotherapy Products Offered
11.8.5 Unum Therapeutics Recent Development
12 Future Forecast
12.1 T-Cell Immunotherapy Market Forecast by Regions
12.1.1 Global T-Cell Immunotherapy Sales Forecast by Regions 2019-2025
12.1.2 Global T-Cell Immunotherapy Revenue Forecast by Regions 2019-2025
12.2 T-Cell Immunotherapy Market Forecast by Product
12.2.1 Global T-Cell Immunotherapy Sales Forecast by Product 2019-2025
12.2.2 Global T-Cell Immunotherapy Revenue Forecast by Product 2019-2025
12.3 T-Cell Immunotherapy Market Forecast by End User
12.4 North America T-Cell Immunotherapy Forecast
12.5 Europe T-Cell Immunotherapy Forecast
12.6 Asia Pacific T-Cell Immunotherapy Forecast
12.7 Central & South America T-Cell Immunotherapy Forecast
12.8 Middle East and Africa T-Cell Immunotherapy Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 T-Cell Immunotherapy Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure T-Cell Immunotherapy Product Picture
Table T-Cell Immunotherapy Market Segments
Table Key Manufacturers T-Cell Immunotherapy Covered
Table Global T-Cell Immunotherapy Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global T-Cell Immunotherapy Sales Market Share by Product 2014-2025
Figure CAR-T Product Picture
Table Major Manufacturers of CAR-T
Figure TCR Product Picture
Table Major Manufacturers of TCR
Figure TIL Therapies Product Picture
Table Major Manufacturers of TIL Therapies
Table Global T-Cell Immunotherapy Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Stomach Cancer
Figure Lung Cancer
Figure Colorectal Cancer
Figure Esophagus Cancer
Figure Pancreatic Cancer
Figure Others
Figure T-Cell Immunotherapy Report Years Considered
Figure Global T-Cell Immunotherapy Market Size 2014-2025 (Million US$)
Figure Global T-Cell Immunotherapy Sales 2014-2025 (K Units)
Table Global T-Cell Immunotherapy Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global T-Cell Immunotherapy Sales by Regions 2014-2019 (K Units)
Table Global T-Cell Immunotherapy Sales Market Share by Regions 2014-2019
Figure Global T-Cell Immunotherapy Sales Market Share by Regions 2014-2019
Figure 2018 Global T-Cell Immunotherapy Sales Market Share by Regions
Table Global T-Cell Immunotherapy Revenue by Regions 2014-2019 (Million US$)
Table Global T-Cell Immunotherapy Revenue Market Share by Regions 2014-2019
Figure Global T-Cell Immunotherapy Revenue Market Share by Regions 2014-2019
Figure 2018 Global T-Cell Immunotherapy Revenue Market Share by Regions
Table Global T-Cell Immunotherapy Sales by Manufacturers (2014-2019) (K Units)
Table Global T-Cell Immunotherapy Sales Share by Manufacturers (2014-2019)
Figure Global T-Cell Immunotherapy Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table T-Cell Immunotherapy Revenue by Manufacturers (2014-2019) (Million USD)
Table T-Cell Immunotherapy Revenue Share by Manufacturers (2014-2019)
Figure T-Cell Immunotherapy Value Share by Manufacturers in 2018
Table Key Manufacturers T-Cell Immunotherapy Price (2014-2019) (USD/Unit)
Table T-Cell Immunotherapy Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers T-Cell Immunotherapy Product Type
Table Date of International Manufacturers Enter into T-Cell Immunotherapy Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global T-Cell Immunotherapy Sales by Product (2014-2019) (K Units)
Table Global T-Cell Immunotherapy Sales Share by Product (2014-2019)
Figure Global T-Cell Immunotherapy Sales Market Share by Product (2014-2019)
Figure Global T-Cell Immunotherapy Sales Market Share by Product in 2018
Table Global T-Cell Immunotherapy Revenue by Product (2014-2019) (Million US$)
Table Global T-Cell Immunotherapy Revenue Share by Product (2014-2019)
Figure Global T-Cell Immunotherapy Revenue Market Share by Product (2014-2019)
Figure Global T-Cell Immunotherapy Revenue Market Share by Product in 2018
Table T-Cell Immunotherapy Price by Product 2014-2019 (USD/Unit)
Table Global T-Cell Immunotherapy Sales by End User (2014-2019) (K Units)
Table Global T-Cell Immunotherapy Sales Share by End User (2014-2019)
Figure Global Sales T-Cell Immunotherapy Market Share by End User (2014-2019)
Figure Global Sales T-Cell Immunotherapy Market Share by End User in 2018
Figure North America T-Cell Immunotherapy Sales Growth Rate 2014-2019 (K Units)
Figure North America T-Cell Immunotherapy Revenue Growth Rate 2014-2019 (Million US$)
Table North America T-Cell Immunotherapy Sales by Countries (2014-2019) (K Units)
Table North America T-Cell Immunotherapy Sales Market Share by Countries (2014-2019)
Figure 2018 North America T-Cell Immunotherapy Sales Market Share by Countries
Table North America T-Cell Immunotherapy Revenue by Countries (2014-2019) (Million US$)
Table North America T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure 2018 North America T-Cell Immunotherapy Revenue Market Share by Countries
Figure United States T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure United States T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (K Units)
Figure Canada T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Canada T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Mexico T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Table North America T-Cell Immunotherapy Sales by Product (2014-2019) (K Units)
Table North America T-Cell Immunotherapy Sales Market Share by Product (2014-2019)
Figure 2018 North America T-Cell Immunotherapy Market Share by Product
Table North America T-Cell Immunotherapy Sales by End User (2014-2019) (K Units)
Table North America T-Cell Immunotherapy Sales Market Share by End User (2014-2019)
Figure 2018 North America T-Cell Immunotherapy Market Share by End User
Figure Europe T-Cell Immunotherapy Sales Growth Rate 2014-2019 (K Units)
Figure Europe T-Cell Immunotherapy Revenue Growth Rate 2014-2019 (Million US$)
Table Europe T-Cell Immunotherapy Sales by Countries (2014-2019) (K Units)
Table Europe T-Cell Immunotherapy Sales Market Share by Countries (2014-2019)
Figure 2018 Europe T-Cell Immunotherapy Sales Market Share by Countries
Table Europe T-Cell Immunotherapy Revenue by Countries (2014-2019) (Million US$)
Table Europe T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe T-Cell Immunotherapy Revenue Market Share by Countries
Figure Germany T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Germany T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure France T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure France T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure UK T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure UK T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Italy T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Russia T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Table Europe T-Cell Immunotherapy Sales by Product (2014-2019) (K Units)
Table Europe T-Cell Immunotherapy Sales Market Share by Product (2014-2019)
Figure 2018 Europe T-Cell Immunotherapy Market Share by Product
Table Europe T-Cell Immunotherapy Sales by End User (2014-2019) (K Units)
Table Europe T-Cell Immunotherapy Sales Market Share by End User (2014-2019)
Figure 2018 Europe T-Cell Immunotherapy Market Share by End User
Figure Asia Pacific T-Cell Immunotherapy Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific T-Cell Immunotherapy Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific T-Cell Immunotherapy Sales by Countries (2014-2019) (K Units)
Table Asia Pacific T-Cell Immunotherapy Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific T-Cell Immunotherapy Sales Market Share by Countries
Table Asia Pacific T-Cell Immunotherapy Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific T-Cell Immunotherapy Revenue Market Share by Countries
Figure China T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure China T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Japan T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Korea T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure India T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure India T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Australia T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Philippines T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Thailand T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Singapore T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific T-Cell Immunotherapy Sales by Product (2014-2019) (K Units)
Table Asia Pacific T-Cell Immunotherapy Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific T-Cell Immunotherapy Market Share by Product
Table Asia Pacific T-Cell Immunotherapy Sales by End User (2014-2019) (K Units)
Table Asia Pacific T-Cell Immunotherapy Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific T-Cell Immunotherapy Market Share by End User
Figure Central & South America T-Cell Immunotherapy Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America T-Cell Immunotherapy Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America T-Cell Immunotherapy Sales by Countries (2014-2019) (K Units)
Table Central & South America T-Cell Immunotherapy Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America T-Cell Immunotherapy Sales Market Share by Countries
Table Central & South America T-Cell Immunotherapy Revenue by Countries (2014-2019) (Million US$)
Table Central & South America T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America T-Cell Immunotherapy Revenue Market Share by Countries
Figure Brazil T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Brazil T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Argentina T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America T-Cell Immunotherapy Sales by Product (2014-2019) (K Units)
Table Central & South America T-Cell Immunotherapy Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America T-Cell Immunotherapy Market Share by Product
Table Central & South America T-Cell Immunotherapy Sales by End User (2014-2019) (K Units)
Table Central & South America T-Cell Immunotherapy Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America T-Cell Immunotherapy Market Share by End User
Figure Middle East and Africa T-Cell Immunotherapy Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa T-Cell Immunotherapy Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa T-Cell Immunotherapy Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa T-Cell Immunotherapy Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa T-Cell Immunotherapy Sales Market Share by Countries
Table Middle East and Africa T-Cell Immunotherapy Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa T-Cell Immunotherapy Revenue Market Share by Countries
Figure GCC Countries T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Turkey T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure Egypt T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa T-Cell Immunotherapy Sales Growth Rate (2014-2019) (K Units)
Figure South Africa T-Cell Immunotherapy Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa T-Cell Immunotherapy Sales by Product (2014-2019) (K Units)
Table Middle East and Africa T-Cell Immunotherapy Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa T-Cell Immunotherapy Market Share by Product
Table Middle East and Africa T-Cell Immunotherapy Sales by End User (2014-2019) (K Units)
Table Middle East and Africa T-Cell Immunotherapy Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa T-Cell Immunotherapy Market Share by End User
Table Adaptimmune Company Details
Table Adaptimmune T-Cell Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Adaptimmune Recent Development
Table Altor Bioscience Corporation Company Details
Table Altor Bioscience Corporation T-Cell Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Altor Bioscience Corporation Recent Development
Table Cellectis Company Details
Table Cellectis T-Cell Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cellectis Recent Development
Table Juno Therapeutics Company Details
Table Juno Therapeutics T-Cell Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Juno Therapeutics Recent Development
Table Kite Pharma Company Details
Table Kite Pharma T-Cell Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kite Pharma Recent Development
Table Novartis Company Details
Table Novartis T-Cell Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Takara Bio Company Details
Table Takara Bio T-Cell Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Takara Bio Recent Development
Table Unum Therapeutics Company Details
Table Unum Therapeutics T-Cell Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Unum Therapeutics Recent Development
Table Global T-Cell Immunotherapy Sales Forecast by Regions 2019-2025 (K Units)
Table Global T-Cell Immunotherapy Sales Market Share Forecast by Regions 2019-2025
Table Global T-Cell Immunotherapy Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global T-Cell Immunotherapy Revenue Market Share Forecast by Regions 2019-2025
Table Global T-Cell Immunotherapy Sales Forecast by Product 2019-2025 (K Units)
Table Global T-Cell Immunotherapy Sales Market Share Forecast by Product 2019-2025
Table Global T-Cell Immunotherapy Revenue Forecast by Product 2019-2025 (Million US$)
Table Global T-Cell Immunotherapy Revenue Market Share Forecast by Product 2019-2025
Table Global T-Cell Immunotherapy Sales Forecast by End User 2019-2025 (K Units)
Table Global T-Cell Immunotherapy Sales Market Share Forecast by End User 2019-2025
Figure North America T-Cell Immunotherapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America T-Cell Immunotherapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe T-Cell Immunotherapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe T-Cell Immunotherapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific T-Cell Immunotherapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific T-Cell Immunotherapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America T-Cell Immunotherapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America T-Cell Immunotherapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa T-Cell Immunotherapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa T-Cell Immunotherapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table T-Cell Immunotherapy Value Chain
Table T-Cell Immunotherapy Customers List
Table T-Cell Immunotherapy Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Castration-Resistant Prostate Cancer (CRPC) /HRPCA Therapeutics Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)
    Published: 31-May-2020        Price: US 2280 Onwards        Pages: 49
    Summary According to 99Strategy, the Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation,......
  • COVID-19 Impact on Small Cell Lung Cancer Therapeutics Market, Global Research Reports 2020-2021
    Published: 29-May-2020        Price: US 3250 Onwards        Pages: 103
    This report covers market size and forecasts of Small Cell Lung Cancer Therapeutics, including the following market information: Global Small Cell Lung Cancer Therapeutics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) Global Small Cell Lung Cancer Therapeutics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) Global Small Cell Lung Cancer Therapeutics Market Size by Region (and K......
  • Immuno-Oncology Market in US - Industry Outlook and Forecast 2020-2026
    Published: 28-May-2020        Price: US 2700 Onwards        Pages: 93
    Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers. This report contains market size and forecasts of Immuno-Oncology in US, including the following market information: US Immuno-Oncology Market Revenue, 2015-2020, 2021-2026, ($ millions) Top Five Competitors in US Immuno-Oncology Market 2019 (%) ......
  • 2015-2027 Global Pancreatic Cancer Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 26-May-2020        Price: US 2960 Onwards        Pages: 127
    The worldwide market for Pancreatic Cancer is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving ......
  • Global Circulating Tumor Cells Market Research Report 2020 (Covid-19 Version)
    Published: 25-May-2020        Price: US 3500 Onwards        Pages: 153
    Summary This report mainly covers Circulating Tumor Cells products, By Types (CTC enrichment, CTC detection and CTC analysis), By Applications (Prostate Cancer, Breast Cancer, Colorectal Cancer Diagnosis and Treatment and Others). Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - CTC enrichment - CTC detecti......
  • COVID-19 Impact on Melanoma Therapeutics Market, Global Research Reports 2020-2021
    Published: 21-May-2020        Price: US 3250 Onwards        Pages: 94
    This report covers market size and forecasts of Melanoma Therapeutics, including the following market information: - Global Melanoma Therapeutics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Melanoma Therapeutics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Melanoma Therapeutics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Mel......
  • 2015-2027 Global Circulating Tumor Cells Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 19-May-2020        Price: US 2960 Onwards        Pages: 132
    The worldwide market for Circulating Tumor Cells is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the dr......
  • Covid-19 Impact on Acute Lymphoblastic Leukemia Therapeutics Market, Global Research Reports 2020-2021
    Published: 19-May-2020        Price: US 3250 Onwards        Pages: 101
    This report covers market size and forecasts of Acute Lymphoblastic Leukemia Therapeutics, including the following market information: - Global Acute Lymphoblastic Leukemia Therapeutics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Acute Lymphoblastic Leukemia Therapeutics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Acute Lymphoblastic Leukemia Therapeutics Market Size by Region (and Key Cou......
  • Global Immuno-Oncology Market Growth (Status and Outlook) 2020-2025
    Published: 18-May-2020        Price: US 3660 Onwards        Pages: 119
    According to this study, over the next five years the Immuno-Oncology market will register a 15.5% CAGR in terms of revenue, the global market size will reach $ 56450 million by 2025, from $ 31750 million in 2019. In particular, this report presents the global revenue market share of key companies in Immuno-Oncology business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Immuno-Oncology market by type, application, ke......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs